Coronary Microcirculation Disorder
Conditions
Interventions
Experimental group:Basic treatment+ Shexiangtongxin dropping pill
Sponsors
Xinhua Hospital Affiliated to Shanghai Jiaotong University School of Medicine
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Entry criteria (meet all inclusion criteria): 1. Patients with typical or atypical chest pain; 2. Coronary stenosis within 20%; 3. BMI index> 25; 4. In line with the diagnostic criteria of qi deficiency and blood stasis type: the clinical evidence can be seen in the face of Shaohua, chest pain, fatigue, left hand and small pulse cannot afford to be mentally ill, accompanied by dark or dark tongue and other symptoms of blood stasis.
Exclusion criteria
Exclusion criteria: Meet any of the following: 1. Aged >80 years Or <18 years; 2. Liver insufficiency; 3. Kidney dysfuction; 4. Heart failure (EF<50%); 5. History of cancer; 6. Mentally abnormal patients; 7. Pregnant patients; 8. Patients who took the medicine containing the ingredients of She xiang Tong xin Pills in the past 3 months; 9. Patients who have participated in other clinical trials within the past 3 months, or who are unable to cooperate.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Adiponectin;leptin;resistin; | — |
Secondary
| Measure | Time frame |
|---|---|
| Chief complaint;Major adverse cardiac events; | — |
Countries
China
Contacts
Public ContactShu Meng
Department of Cardiology, Xinhua Hospital, School of Medicine, Shanghai Jiaotong University
Outcome results
None listed